Kallum Titchmarsh
Stock Analyst at Morgan Stanley
Total Price Targets
15
Stocks Covered
11
Sectors
Healthcare
Most Recent
Mar 5, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Kallum Titchmarsh
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| VCYT | Veracyte, Inc. | $37.00 | $33.03 | +12.0% | 1 | Mar 5, 2026 |
| GRAL | GRAIL, Inc. | $60.00 | $54.34 | +10.4% | 1 | Feb 24, 2026 |
| MTD | Mettler-Toledo International Inc. | $1475.00 | $1268.62 | +16.3% | 2 | Feb 9, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $21.00 | $14.18 | +48.1% | 1 | Dec 1, 2025 |
| CRL | Charles River Laboratories International, Inc. | $185.00 | $165.56 | +11.7% | 1 | Dec 1, 2025 |
| PSNL | Personalis, Inc. | $11.00 | $5.67 | +93.8% | 1 | Dec 1, 2025 |
| TXG | 10x Genomics, Inc. | $20.00 | $22.36 | -10.6% | 1 | Dec 1, 2025 |
| INSP | Inspire Medical Systems, Inc. | $200.00 | $57.23 | +249.5% | 3 | May 6, 2025 |
| EMBC | Embecta Corp. | $20.00 | $9.25 | +116.2% | 2 | Dec 2, 2024 |
| GMED | Globus Medical, Inc. | $100.00 | $91.62 | +9.1% | 1 | Dec 2, 2024 |
| PEN | Penumbra, Inc. | $210.00 | $325.86 | -35.6% | 1 | Jul 15, 2024 |
Recent Activity
- Mar 5, 2026— Set$37.00price target onVCYT(Veracyte, Inc.)
- Feb 24, 2026— Set$60.00price target onGRAL(GRAIL, Inc.)
- Feb 9, 2026— Set$1475.00price target onMTD(Mettler-Toledo International Inc.)
- Dec 1, 2025— Set$21.00price target onADPT(Adaptive Biotechnologies Corporation)
- Dec 1, 2025— Set$185.00price target onCRL(Charles River Laboratories International, Inc.)
- Dec 1, 2025— Set$1550.00price target onMTD(Mettler-Toledo International Inc.)
- Dec 1, 2025— Set$11.00price target onPSNL(Personalis, Inc.)
- Dec 1, 2025— Set$20.00price target onTXG(10x Genomics, Inc.)
- May 6, 2025— Set$200.00price target onINSP(Inspire Medical Systems, Inc.)
- Dec 2, 2024— Set$100.00price target onGMED(Globus Medical, Inc.)
- Dec 2, 2024— Set$20.00price target onEMBC(Embecta Corp.)
- Jul 15, 2024— Set$210.00price target onPEN(Penumbra, Inc.)
- Jul 15, 2024— Set$12.00price target onEMBC(Embecta Corp.)
- Jul 15, 2024— Set$210.00price target onINSP(Inspire Medical Systems, Inc.)
- Mar 19, 2024— Set$250.00price target onINSP(Inspire Medical Systems, Inc.)
Frequently Asked Questions
Who is Kallum Titchmarsh?
Kallum Titchmarsh is a stock analyst at Morgan Stanley covering 11 stocks primarily in Healthcare. They have issued 15 price targets since Mar 19, 2024.
What stocks does Kallum Titchmarsh cover?
Kallum Titchmarsh currently covers 11 stocks, including INSP, MTD, EMBC, VCYT, GRAL.
What is Kallum Titchmarsh's latest price target?
Kallum Titchmarsh's most recent price target was $37.00 on VCYT (Veracyte, Inc.), set on Mar 5, 2026.
What is Kallum Titchmarsh's highest price target?
Kallum Titchmarsh's highest issued price target is $1550.00 on MTD, set on Dec 1, 2025.
More Analysts at Morgan Stanley
Coverage based on publicly published price targets. Not investment advice.